24 Mar 2022
Incannex to Acquire APIRx Pharmaceuticals USA, LLC
Author: admintech | Filed under: Press ReleaseHighlights: APIRx has twenty-two (22) active clinical and pre-clinical research and development projects therapeutic candidates are targeted at treating pain, dementia, Parkinson’s disease, restless leg syndrome, gastrointestinal diseases, periodontitis, addiction disorders, skin…